The Association of Non-Cardiac ECMO With Influenza Incidence: A Time Series Analysis

References

1. 1.↵
   1. Peek GJ,
   2. Mugford M,
   3. Tiruvoipati R,
   4. Wilson A,
   5. Allen E,
   6. Thalanany MM,
   7. et al

   . Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009;374(9698):1351–1363.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.
   1. Lindskov C,
   2. Jensen RH,
   3. Sprogoe P,
   4. Klaaborg KE,
   5. Kirkegaard H,
   6. Severinsen IK,
   7. et al

   . Extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure. Acta Anaesthesiol Scand 2013;57(3):303–311.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Combes A,
   2. Bacchetta M,
   3. Brodie D,
   4. Müller T,
   5. Pellegrino V

   . Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care 2012;18(1):99–104.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Davies A,
   2. Jones D,
   3. Bailey M,
   4. Beca J,
   5. Bellomo R,
   6. Blackwell N,
   7. et al

   . Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009;302(17):1888–1889.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Natt BS,
   2. Desai H,
   3. Singh N,
   4. Poongkunran C,
   5. Parthasarathy S,
   6. Bime C

   . Extracorporeal membrane oxygenation for ARDS: national trends in the United States 2008-2012. Respir Care 2016;61(10):1293–1298.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Lagacé-Wiens PR,
   2. Rubinstein E,
   3. Gumel A

   . Influenza epidemiology: past, present, and future. Crit Care Med 2010;38:e1–e9.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Kumar A,
   2. Zarychanski R,
   3. Pinto R,
   4. Cook DJ,
   5. Marshall J,
   6. Lacroix J,
   7. et al

   .; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302(17):1872–1879.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Michaels AJ,
   2. Hill JG,
   3. Long WB,
   4. Young BP,
   5. Sperley BP,
   6. Shanks TR,
   7. Morgan LJ

   . Adult refractory hypoxemic acute respiratory distress syndrome treated with extracorporeal membrane oxygenation: the role of a regional referral center. Am J Surg 2013;205(5):492–498.

   OpenUrl
9. 9.↵
   1. Warren-Gash C,
   2. Bhaskaran K,
   3. Hayward A,
   4. Leung GM,
   5. Lo SV,
   6. Wong CM,
   7. et al

   . Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong. J Infect Dis 2011;203(12):1710–1708.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Kwong J,
    2. Schwartz K,
    3. Campitelli M,
    4. Chung H,
    5. Crowcroft N,
    6. Karnauchow T,
    7. et al

    . Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 2018;378(4):345–353.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Lachin J

    . Biostatistical methods: the assessment of relative risk, 2nd ed. Hoboken, NJ: Wiley; 2010, 382–427.
12. 12.↵
    1. Frome EL,
    2. Checkoway H

    . Epidemiologic programs for computers and calculators: use of Poisson regression models in estimating incidence rate and ratios. Am J Epidemiology 1985;121(2):309–323.

    OpenUrlPubMedWeb of Science